Nalaganje...
Clinical benefit and tolerability of adjuvant intraperitoneal chemotherapy in patients who have or have not received neoadjuvant chemotherapy for advanced ovarian cancer
BACKGROUND: Adjuvant chemotherapy using intraperitoneal (IP) treatment has demonstrated survival benefit over intravenous (IV) therapy alone in patients treated with upfront debulking surgery for advanced stage ovarian cancer. Neoadjuvant chemotherapy followed by interim surgery and adjuvant chemoth...
Shranjeno v:
| izdano v: | World J Clin Oncol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6556590/ https://ncbi.nlm.nih.gov/pubmed/31205865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v10.i5.201 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|